Clinical Trial Update: Study of Levalbuterol and Racemic Albuterol in Pediatric Subjects With Reactive Airways Disease (RAD) [Phase 3]

View source ↗

Summary

A Phase 3 pediatric trial comparing levalbuterol and racemic albuterol for Reactive Airways Disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Reactive Airways Disease

Drugs mentioned

• Ventolin (albuterol)
• Xopenex (Levalbuterol)

Snippet

Sponsor: Sumitomo Pharma America, Inc. | Conditions: Reactive Airways Disease (RAD) | Phase 3 | Status: COMPLETED